25Jan
Financial Daily Dose 1.25.2021 | Top Story: Merck Abandons Covid Vaccine Effort Over Ineffective Results
U.S. drug giant Merck is shuttering its coronavirus vaccine development “after early trial data showed [its pair of vaccines] failed to generate immune responses comparable to natural infection or existing vaccines.”...
By:
Robins Kaplan LLP
Related
The energy and chemicals industries play a central role in our economy and regularly capture the att...
Read More >
Given the recent tropical systems that have hit Texas including Laura and Beta (who still has not de...
Read More >
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses ope...
Read More >
On May 18, 2020, California Senate Bill 977 (“SB-977”) was passed out of the California Senate He...
Read More >
The National Labor Relations Board (NLRB) recently provided guidance in Cordúa Restaurants, Inc., 36...
Read More >
On February 15, 2019, the U.S. District Court for the Southern District of New York issued its rulin...
Read More >